{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:01:39Z","timestamp":1792422099190,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["W2421115"],"award-info":[{"award-number":["W2421115"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52203201"],"award-info":[{"award-number":["52203201"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20591"],"award-info":[{"award-number":["U23A20591"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472144"],"award-info":[{"award-number":["82472144"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52273158"],"award-info":[{"award-number":["52273158"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52173149"],"award-info":[{"award-number":["52173149"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004032","name":"Jilin University","doi-asserted-by":"publisher","award":["2023B01"],"award-info":[{"award-number":["2023B01"]}],"id":[{"id":"10.13039\/501100004032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013061","name":"Jilin Provincial Scientific and Technological Development Program","doi-asserted-by":"publisher","award":["20210509005RQ"],"award-info":[{"award-number":["20210509005RQ"]}],"id":[{"id":"10.13039\/501100013061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013061","name":"Jilin Provincial Scientific and Technological Development Program","doi-asserted-by":"publisher","award":["20220204018YY"],"award-info":[{"award-number":["20220204018YY"]}],"id":[{"id":"10.13039\/501100013061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013061","name":"Jilin Provincial Scientific and Technological Development Program","doi-asserted-by":"publisher","award":["20210101114JC"],"award-info":[{"award-number":["20210101114JC"]}],"id":[{"id":"10.13039\/501100013061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013061","name":"Jilin Provincial Scientific and Technological Development Program","doi-asserted-by":"publisher","award":["20240101002JJ"],"award-info":[{"award-number":["20240101002JJ"]}],"id":[{"id":"10.13039\/501100013061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jconrel.2025.02.020","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T06:59:21Z","timestamp":1739861961000},"page":"760-772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Poly(amino acid) nanoformulation of cyclin-dependent kinase 4 and 6 inhibitor for molecularly targeted immunotherapy in triple-negative breast cancer"],"prefix":"10.1016","volume":"380","author":[{"given":"Xue","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songjie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuechong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.02.020_bb0005","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41420-022-01030-4","article-title":"Hyperglycemia induces gastric carcinoma proliferation and migration via the Pin1\/BRD4 pathway","volume":"8","author":"Yu","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41586-022-04798-8","article-title":"Core control principles of the eukaryotic cell cycle","volume":"607","author":"Basu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.02.020_bb0015","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1158\/1535-7163.MCT-20-0807","article-title":"Activity of combined androgen receptor antagonism and cell cycle inhibition in androgen receptor positive triple negative breast cancer","volume":"20","author":"Christenson","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-00880-8","article-title":"The application and prospect of CDK4\/6 inhibitors in malignant solid tumors","volume":"13","author":"Du","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0025","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb2210","article-title":"Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4\/6 inhibition","volume":"6","author":"Fassl","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.breast.2018.10.001","article-title":"Targeting CDK4\/6 pathways and beyond in breast cancer","volume":"43","author":"Ribnikar","year":"2019","journal-title":"Breast"},{"key":"10.1016\/j.jconrel.2025.02.020_bb0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41571-023-00840-4","article-title":"The CDK4\/6 inhibitor revolution\u2014A game-changing era for breast cancer treatment","volume":"21","author":"Morrison","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0040","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41568-022-00456-3","article-title":"Targeting CDK4 and CDK6 in cancer","volume":"22","author":"Goel","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.02.020_bb0045","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(20)30642-2","article-title":"Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): Interim analysis of a multicentre, open-label, randomised, phase 3 study","volume":"22","author":"Mayer","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0050","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(20)30165-3","article-title":"Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: Past, present, and future","volume":"395","author":"Spring","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.02.020_bb0055","doi-asserted-by":"crossref","first-page":"14168","DOI":"10.1039\/c2jm32033a","article-title":"Intracellular microenvironment responsive PEGylated polypeptide nanogels with ionizable cores for efficient doxorubicin loading and triggered release","volume":"22","author":"Shi","year":"2012","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0060","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1016\/j.celrep.2018.02.053","article-title":"The CDK4\/6 inhibitor abemaciclib induces a T cell inflamed tumor microenvironment and enhances the efficacy of PD-L1 checkpoint blockade","volume":"22","author":"Schaer","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0065","first-page":"3473","article-title":"Intelligent nanogels with self-adaptive responsiveness for improved tumor drug delivery and augmented chemotherapy","volume":"6","author":"Li","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0070","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.2147\/IJN.S362418","article-title":"Fully natural lecithin encapsulated nano-resveratrol for anti-cancer therapy","volume":"17","author":"Liang","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0075","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.apsb.2019.06.008","article-title":"Enhanced stability and efficacy of GEM-TOS prodrug by co-assembly with antimetastatic shell LMWH-TOS","volume":"10","author":"Guo","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2025.02.020_bb0080","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.celrep.2015.12.094","article-title":"Metabolic reprogramming of pancreatic cancer mediated by CDK4\/6 inhibition elicits unique vulnerabilities","volume":"14","author":"Franco","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109271","article-title":"Metabolic modulation by CDK4\/6 inhibitor promotes chemokine-mediated recruitment of T cells into mammary tumors","volume":"35","author":"Uzhachenko","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0090","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/cas.14419","article-title":"Abemaciclib induces atypical cell death in cancer cells characterized by formation of cytoplasmic vacuoles derived from lysosomes","volume":"111","author":"Hino","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202300354","article-title":"Advances in immunogenic cell death for cancer immunotherapy","volume":"7","author":"Ding","year":"2023","journal-title":"Small Methods"},{"key":"10.1016\/j.jconrel.2025.02.020_bb0100","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13045-020-00950-x","article-title":"HMGB1 in inflammation and cancer","volume":"13","author":"Wang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0105","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41467-017-00600-w","article-title":"Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics","volume":"8","author":"Bertrand","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0110","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1039\/C7BM00128B","article-title":"Bioresorbable polypeptide-based comb-polymers efficiently improves the stability and pharmacokinetics of proteins in vivo","volume":"5","author":"Turabee","year":"2017","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0115","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41578-020-00269-6","article-title":"Targeted drug delivery strategies for precision medicines","volume":"6","author":"Manzari","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0120","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature23465","article-title":"CDK4\/6 inhibition triggers anti-tumour immunity","volume":"548","author":"Goel","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.02.020_bb0125","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1158\/0008-5472.CAN-17-2210","article-title":"Combined CDK4\/6 and PI3K\u03b1 inhibition is synergistic and immunogenic in triple-negative breast cancer","volume":"77","author":"Teo","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0130","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi3821","article-title":"LncRNA EILA promotes CDK4\/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein","volume":"9","author":"Cai","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0140","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","article-title":"Metabolic programming and immune suppression in the tumor microenvironment","volume":"41","author":"Arner","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2025.02.020_bb0145","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1158\/2159-8290.CD-17-0915","article-title":"CDK4\/6 inhibition augments antitumor immunity by enhancing T cell activation","volume":"8","author":"Deng","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0150","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023739118","article-title":"Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature25015","article-title":"Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance","volume":"553","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.02.020_bb0160","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1158\/2159-8290.CD-20-1540","article-title":"Inhibition of CDK4\/6 promotes CD8 T cell memory formation","volume":"11","author":"Heckler","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0165","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1158\/2159-8290.CD-20-1554","article-title":"CDK4\/6 inhibition promotes antitumor immunity through the induction of T cell memory","volume":"11","author":"Lelliott","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0170","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3389\/fimmu.2019.00333","article-title":"Chemokines modulate immune surveillance in tumorigenesis, metastasis, and response to immunotherapy","volume":"10","author":"Vilgelm","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0175","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.immuni.2018.03.004","article-title":"Cancer-cell-intrinsic mechanisms shaping the tumor immune landscape","volume":"48","author":"Wellenstein","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.02.020_bb0180","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41571-024-00859-1","article-title":"Dendritic cells as orchestrators of anticancer immunity and immunotherapy","volume":"21","author":"Heras-Murillo","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0185","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ni1549","article-title":"Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer","volume":"9","author":"Tone","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188912","article-title":"Immunomodulatory effects of CDK4\/6 inhibitors","volume":"1878","author":"Zhang","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.02.020_bb0195","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1158\/1078-0432.CCR-17-0754","article-title":"MONARCH 1, a phase II study of abemaciclib, a CDK4 and CDK6 inhibitor, as a single agent, in patients with refractory HR+\/HER2\u2212 metastatic breast cancer","volume":"23","author":"Dickler","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.02.020_bb0200","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","article-title":"Neutrophils in cancer: heterogeneous and multifaceted","volume":"22","author":"Hedrick","year":"2022","journal-title":"Nat. Rev. Immunol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925001336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925001336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:50:44Z","timestamp":1770141044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925001336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":40,"alternative-id":["S0168365925001336"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.02.020","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poly(amino acid) nanoformulation of cyclin-dependent kinase 4 and 6 inhibitor for molecularly targeted immunotherapy in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}